https://m2squareconsultancy.com/reports/medical-nutrition-market

https://m2squareconsultancy.com/reports/medical-waste-management-market

Top 10 Players Shaping the Global Hepatitis E Diagnostic Tests Market (2026–2034) According to a newly published market research report by 24LifeSciences, global Hepatitis E Diagnostic Tests market is valued at USD 40.1 million in 2026 and is projected to reach USD 47.1 million by 2034, growing at a compound annual growth rate (CAGR) of 2.4% during the forecast period. Hepatitis E diagnostic tests are critical medical tools designed to detect the presence of the Hepatitis E Virus (HEV), an RNA virus responsible for acute liver inflammation. These tests are indispensable for confirming infection, particularly during outbreaks and for high-risk populations such as pregnant women, immunocompromised individuals, and patients with pre-existing liver conditions. The primary diagnostic methodologies include Enzyme-Linked Immunosorbent Assay (ELISA) kits, which identify IgM and IgG antibodies, and advanced molecular techniques like Reverse Transcription-Polymerase Chain Reaction (RT-PCR) tests that detect viral RNA directly, offering high specificity and sensitivity. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9474/hepatitis-e-diagnostic-tests-market

Top 7 Innovations Driving the Portable Blood and Infusion Warmer Industry Forward According to a newly published market research report by 24LifeSciences, global portable blood and infusion warmer market is valued at USD 680 million in 2026 and is projected to reach USD 1.05 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period. Portable blood and infusion warmers are critical medical devices designed to safely raise the temperature of intravenous fluids, blood products, and other resuscitation fluids to near-normal body temperature before administration to a patient. These compact, often battery-powered devices are essential for preventing hypothermia, which can lead to severe complications such as coagulopathy, cardiac arrhythmias, increased infection risk, and prolonged hospital stays. Their application spans diverse settings including emergency departments, operating rooms, military field hospitals, ambulances, and disaster response scenarios, underscoring their vital role in modern targeted temperature management and improved patient outcomes. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10159/portable-blood-and-infusion-warmer-market

What Is the Future of the Medical X-ray Film Market? Growth Forecasts & Insights According to a newly published market research report by 24LifeSciences, global Medical X-ray Film market is valued at USD 908 million in 2026 and is projected to reach USD 1,090 million by 2034, growing at a compound annual growth rate (CAGR) of 2.7% during the forecast period. Medical X-ray Film is a specialized light-sensitive material formulated to capture diagnostic images when exposed to X-ray radiation. Despite the widespread adoption of digital radiography, these films remain essential for producing high-resolution, permanent images in various clinical settings, particularly where cost-effectiveness and reliability are prioritized. The primary product types include Thermal Film and Ink-jet Film, both of which continue to serve critical roles in global healthcare diagnostics. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7575/medical-x-ray-film-market

Chemo Graded Nitrile Gloves Market to Reach USD 4.6 Billion by 2034 | Key Trends According to a newly published market research report by 24LifeSciences, global Chemo Graded Nitrile Powder-free Medical Examination Gloves market is valued at USD 2.8 billion in 2026 and is projected to reach USD 4.6 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period. Chemo Graded Nitrile Powder-free Medical Examination Gloves are specialty personal protective equipment (PPE) specifically engineered for handling hazardous drugs, particularly cytotoxic agents used in chemotherapy treatments. These gloves undergo rigorous testing per standards like ASTM D6978 to ensure superior permeation resistance, offering healthcare workers critical protection against chemical exposure. Their powder-free nature is essential for maintaining sterile environments in oncology wards, compounding pharmacies, and surgical settings, minimizing the risk of contamination and allergic reactions. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10309/chemo-graded-nitrile-powder-free-medical-examination-gloves-market

Rising CKD and ESRD Fuel Demand for Advanced Hemodialysis Filtration According to a newly published market research report by 24LifeSciences, global hemodialysis filtration devices market was valued at USD 14.9 billion in 2026 and is projected to reach USD 22.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period. Hemodialysis filtration devices are sophisticated medical systems essential for performing hemodialysis, a life-sustaining renal replacement therapy for patients with end-stage renal disease. These advanced machines integrate multiple components to filter waste products and excess fluids from the blood, and they are comprised of a host system with dialysis pumps, ultrafiltration pumps, blood pumps, and sophisticated safety monitoring systems. Their role is critical in managing conditions where kidney function has severely declined, providing a vital therapeutic intervention that supports patient survival and quality of life. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10278/hemodialysis-filtration-devices-market

Rising CKD and ESRD Fuel Demand for Advanced Hemodialysis Filtration According to a newly published market research report by 24LifeSciences, global hemodialysis filtration devices market was valued at USD 14.9 billion in 2026 and is projected to reach USD 22.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period. Hemodialysis filtration devices are sophisticated medical systems essential for performing hemodialysis, a life-sustaining renal replacement therapy for patients with end-stage renal disease. These advanced machines integrate multiple components to filter waste products and excess fluids from the blood, and they are comprised of a host system with dialysis pumps, ultrafiltration pumps, blood pumps, and sophisticated safety monitoring systems. Their role is critical in managing conditions where kidney function has severely declined, providing a vital therapeutic intervention that supports patient survival and quality of life. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10278/hemodialysis-filtration-devices-market

https://univdatos.com/news/medical-tourism-market

Why Needle-Free Diabetes Care Is Gaining Traction | Market Size & Forecast According to a newly published market research report by 24LifeSciences, global needle-free diabetes care market was valued at USD 5.65 billion in 2026 and is projected to reach USD 11.52 billion by 2034, growing at a compound annual growth rate (CAGR) of 10.8% during the forecast period. Needle-free diabetes care represents a revolutionary segment of medical technology designed to manage diabetes without traditional hypodermic needles, addressing critical challenges like needle phobia, pain, and infection risk associated with daily injections. These advanced solutions encompass insulin patches, jet injectors, insulin pumps, inhalable insulin systems, and continuous glucose monitoring (CGM) devices that eliminate finger-prick blood sampling. This paradigm shift enhances patient compliance and quality of life, particularly for pediatric and geriatric populations who struggle with conventional injection methods. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8939/needle-free-diabetes-care-market

AI and Biomarker Advancements Transforming Companion Diagnostic Tests in Oncology According to a newly published market research report by 24LifeSciences, global companion diagnostic tests in oncology market was valued at USD 4.37 billion in 2024 and is projected to reach USD 8.54 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.3% during the forecast period 2025–2032. Companion diagnostic tests in oncology are in vitro medical devices that provide essential information for the safe and effective use of a corresponding therapeutic product. These tests are crucial for identifying specific biomarkers, such as genetic mutations or protein expressions, which determine a patient's eligibility for targeted cancer therapy. This personalized approach ensures treatments are administered only to patients most likely to benefit, thereby improving clinical outcomes and optimizing healthcare resource allocation. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/945 companion-diagnostic-tests-in-oncology-market

https://univdatos.com/news/ai-in-medical-diagnostics-market